Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 July 2008, Vol. 112, No. 2, pp. 214-215.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Haltiwanger, R. S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haltiwanger, R. S.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

InsideBlood

HEMATOPOIESIS & STEM CELLS

Comment on Zhou et al, page 308

Unsweetened Notch leads to myeloproliferation

Robert S. Haltiwanger

STONY BROOK UNIVERSITY

The article by Zhou and colleagues in this issue of Blood highlights the importance of Notch glycosylation in suppression of myelogenesis.

The extracellular domain of all 4 mammalian Notch receptors contains 29 to 36 epidermal growth factor (EGF)–like repeats, many of which are predicted to be modified with 2 unusual carbohydrates: O-linked fucose and O-linked glucose. Work in a number of laboratories has revealed that O-fucosylation is essential for Notch function in many contexts,1 and a recent report has shown that O-glucosylation is essential for Notch function in Drosophila.2 In addition, elongation of O-fucose by members of the Fringe family of β1,3-N-acetylglucosaminyltransferases modulates Notch activity. Several years ago, Smith et al developed a mouse lacking a key enzyme in GDP-fucose biosynthesis (FX–/–).3 These mice lack all forms of fucosylation, including O-fucosylation of Notch, and do not survive long after birth unless fucose is added to their diet. A salvage pathway uses the fucose to rescue GDP-fucose biosynthesis, restoring fucosylation. In the absence of fucose, the FX–/– mice display a profound neutrophilia. Part of this neutrophilia can be explained by loss of selectin ligands (Sialyl Lewis x contains fucose), but proliferation of myeloid progenitor cells suggests that myelopoiesis is being stimulated. Zhou and coworkers have now examined the proliferation of myeloid lineages in FX–/– mice and attributed it to loss of fucose-dependent Notch activation in myeloid progenitors. The authors present compelling data that suggests a role for Notch activation in suppression of myeloid differentiation, a somewhat controversial area. Another recent publication highlighted the importance of O-fucose at a specific site on Notch1 in T-cell development.4 Ge and Stanley generated a mouse in which endogenous Notch1 was replaced with a mutant lacking the O-fucosylation site in the ligand-binding domain (within EGF repeat 12). Homozygotes developed fairly normally but had a reduced number of T cells, suggesting that O-fucosylation of Notch1 at EGF repeat 12 is important for T-cell development.

These results raise a number of interesting questions. All 4 receptors should be unfucosylated in FX–/– mice, but it is not known which Notch receptor is responsible for suppression of myeloproliferation. As mentioned, modification of O-fucose by Fringe modulates Notch activity. In the absence of Fringe, O-fucose remains a monosaccharide, but in the presence of Fringe it is elongated to a tetrasaccharide. The relevant structures of the O-fucose glycans that are lost in FX–/– mice are unknown. Because O-fucosylation of EGF repeat 12 in Notch1 plays such an important role in T-cell development, it would be interesting to know if loss of this specific fucose also suppresses myelogenesis. The future of Notch and hematopoiesis certainly looks sweet.

Footnotes

Conflict-of-interest disclosure: The author declares no competing financial interests. {blacksquare}

REFERENCES

  1. Stanley P. Regulation of Notch signaling by glycosylation. Curr Opin Struct Biol. 2007;17:530–535.[CrossRef][Medline] [Order article via Infotrieve]

  2. Acar M, Jafar-Nejad H, Takeuchi H, et al. Rumi is a CAP10 domain glycosyltransferase that modifies Notch and is required for Notch signaling. Cell. 2008;132:247–258.[CrossRef][Medline] [Order article via Infotrieve]

  3. Smith PL, Myers JT, Rogers CE, et al. Conditional control of selectin ligand expression and global fucosylation events in mice with a targeted mutation at the FX locus. J Cell Biol. 2002;158:801–815.[Abstract/Free Full Text]

  4. Ge C, Stanley P. The O-fucose glycan in the ligand-binding domain of Notch1 regulates embryogenesis and T cell development. Proc Natl Acad Sci U S A. 2008;105:1539–1544.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Notch-dependent control of myelopoiesis is regulated by fucosylation
Lan Zhou, Lebing Wei Li, Quanjian Yan, Bronislawa Petryniak, Yunfang Man, Charles Su, Jeongsup Shim, Stephanie Chervin, and John B. Lowe
Blood 2008 112: 308-319. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Haltiwanger, R. S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haltiwanger, R. S.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020